LMAT News and Press, LeMaitre Vascular Inc. From 02/26/21

The following slide deck was published by LeMaitre Vascular, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: LeMaitre Vascular, Inc. 2020 Q4 - Results - Earnings Call Presentation

Image source: The Motley Fool. LeMaitre Vascular inc (NASDAQ: LMAT) Q4 2020 Earnings Call Feb 25, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: LeMaitre Vascular inc (LMAT) Q4 2020 Earnings Call Transcript

LeMaitre Vascular (LMAT) declares $0.11/share quarterly dividend, 15.8% increase from prior dividend of $0.10.Forward yield 0.94%Payable March 25; for shareholders of record March 9; ex-div March 8.See LMAT Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: ...

LeMaitre Vascular (LMAT): Q4 GAAP EPS of $0.34 beats by $0.05.Revenue of $37.5M (+24.3% Y/Y) beats by $1.92M.Press Release For further details see: LeMaitre Vascular EPS beats by $0.05, beats on revenue

BURLINGTON, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2020 results and announced an $0.11/share quarterly dividend. Q4 2020 Results Sales of $37.5mm, +24% (+3% organic) vs. Q...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead On tap for next week, investors will continue to size up improving economic data and the steady decline in COVID-19 case...

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets. LeMaitre Vascular Inc. manufactures and distributes medical devices for the tre...

BURLINGTON, Mass., Jan. 27, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2020 financial results on Thursday, February 25, 2021, after the market close. The company has scheduled a conference call for 5:...

The following slide deck was published by LeMaitre Vascular, Inc. in conjunction with this event. For further details see: LeMaitre Vascular (LMAT) Investor Presentation - Slideshow

The LeMaitre's corporate health partly depends on how much its sales reps can do to overcome current blocks, and how soon the pandemic ends. CEO George LeMaitre has indicated a willingness to use more debt for future acquisitions. The valuation might not be as bad as at first glan...